17042884|t|Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
17042884|a|OBJECTIVES: To evaluate extrapyramidal symptoms (EPS), including akathisia, with quetiapine in patients with bipolar mania. METHODS: Data were analyzed from four similarly designed, randomized, double-blind, 3- to 12-week studies. Two studies evaluated quetiapine monotherapy (up to 800 mg/day) (n = 209) versus placebo (n = 198), with lithium or haloperidol monotherapy as respective active controls. Two studies evaluated quetiapine (up to 800 mg/day) in combination with a mood stabilizer (lithium or divalproex, QTP + Li/DVP) (n = 196) compared to placebo and mood stabilizer (PBO + Li/DVP) (n = 203). Extrapyramidal symptoms were evaluated using the Simpson-Angus Scale (SAS), the Barnes Akathisia Rating Scale (BARS), adverse event reports and anticholinergic drug usage. RESULTS: The incidence of EPS-related adverse events, including akathisia, was no different with quetiapine monotherapy (12.9%) than with placebo (13.1%). Similarly, EPS-related adverse events with QTP + Li/DVP (21.4%) were no different than with PBO + Li/DVP (19.2%). Adverse events related to EPS occurred in 59.6% of patients treated with haloperidol (n = 99) monotherapy, whereas 26.5% of patients treated with lithium (n = 98) monotherapy experienced adverse events related to EPS. The incidence of akathisia was low and similar with quetiapine monotherapy (3.3%) and placebo (6.1%), and with QTP + Li/DVP (3.6%) and PBO + Li/DVP (4.9%). Lithium was associated with a significantly higher incidence (p < 0.05) of tremor (18.4%) than quetiapine (5.6%); cerebellar tremor, which is a known adverse effect of lithium, may have contributed to the elevated rate of tremor in patients receiving lithium therapy. Haloperidol induced a significantly higher incidence (p < 0.001) of akathisia (33.3% versus 5.9%), tremor (30.3% versus 7.8%), and extrapyramidal syndrome (35.4% versus 5.9%) than quetiapine. No significant differences were observed between quetiapine and placebo on SAS and BARS scores. Anticholinergic use was low and similar with quetiapine or placebo. CONCLUSIONS: In bipolar mania, the incidence of EPS, including akathisia, with quetiapine therapy is similar to that with placebo.
17042884	27	50	extrapyramidal symptoms	DiseaseOrPhenotypicFeature	D001480
17042884	52	55	EPS	DiseaseOrPhenotypicFeature	D001480
17042884	62	72	quetiapine	ChemicalEntity	C069541
17042884	98	106	patients	OrganismTaxon	9606
17042884	112	125	bipolar mania	DiseaseOrPhenotypicFeature	D001714
17042884	151	174	extrapyramidal symptoms	DiseaseOrPhenotypicFeature	D001480
17042884	176	179	EPS	DiseaseOrPhenotypicFeature	D001480
17042884	192	201	akathisia	DiseaseOrPhenotypicFeature	D017109
17042884	208	218	quetiapine	ChemicalEntity	C069541
17042884	222	230	patients	OrganismTaxon	9606
17042884	236	249	bipolar mania	DiseaseOrPhenotypicFeature	D001714
17042884	380	390	quetiapine	ChemicalEntity	C069541
17042884	463	470	lithium	ChemicalEntity	D008094
17042884	474	485	haloperidol	ChemicalEntity	D006220
17042884	551	561	quetiapine	ChemicalEntity	C069541
17042884	620	627	lithium	ChemicalEntity	D008094
17042884	631	641	divalproex	ChemicalEntity	D014635
17042884	643	646	QTP	ChemicalEntity	C069541
17042884	649	651	Li	ChemicalEntity	D008094
17042884	652	655	DVP	ChemicalEntity	D014635
17042884	714	716	Li	ChemicalEntity	D008094
17042884	717	720	DVP	ChemicalEntity	D014635
17042884	733	756	Extrapyramidal symptoms	DiseaseOrPhenotypicFeature	D001480
17042884	877	897	anticholinergic drug	ChemicalEntity	D018680
17042884	931	934	EPS	DiseaseOrPhenotypicFeature	D001480
17042884	969	978	akathisia	DiseaseOrPhenotypicFeature	D017109
17042884	1002	1012	quetiapine	ChemicalEntity	C069541
17042884	1071	1074	EPS	DiseaseOrPhenotypicFeature	D001480
17042884	1103	1106	QTP	ChemicalEntity	C069541
17042884	1109	1111	Li	ChemicalEntity	D008094
17042884	1112	1115	DVP	ChemicalEntity	D014635
17042884	1158	1160	Li	ChemicalEntity	D008094
17042884	1161	1164	DVP	ChemicalEntity	D014635
17042884	1200	1203	EPS	DiseaseOrPhenotypicFeature	D001480
17042884	1225	1233	patients	OrganismTaxon	9606
17042884	1247	1258	haloperidol	ChemicalEntity	D006220
17042884	1298	1306	patients	OrganismTaxon	9606
17042884	1320	1327	lithium	ChemicalEntity	D008094
17042884	1387	1390	EPS	DiseaseOrPhenotypicFeature	D001480
17042884	1409	1418	akathisia	DiseaseOrPhenotypicFeature	D017109
17042884	1444	1454	quetiapine	ChemicalEntity	C069541
17042884	1503	1506	QTP	ChemicalEntity	C069541
17042884	1509	1511	Li	ChemicalEntity	D008094
17042884	1512	1515	DVP	ChemicalEntity	D014635
17042884	1533	1535	Li	ChemicalEntity	D008094
17042884	1536	1539	DVP	ChemicalEntity	D014635
17042884	1548	1555	Lithium	ChemicalEntity	D008094
17042884	1623	1629	tremor	DiseaseOrPhenotypicFeature	D014202
17042884	1643	1653	quetiapine	ChemicalEntity	C069541
17042884	1673	1679	tremor	DiseaseOrPhenotypicFeature	D014202
17042884	1716	1723	lithium	ChemicalEntity	D008094
17042884	1770	1776	tremor	DiseaseOrPhenotypicFeature	D014202
17042884	1780	1788	patients	OrganismTaxon	9606
17042884	1799	1806	lithium	ChemicalEntity	D008094
17042884	1816	1827	Haloperidol	ChemicalEntity	D006220
17042884	1884	1893	akathisia	DiseaseOrPhenotypicFeature	D017109
17042884	1915	1921	tremor	DiseaseOrPhenotypicFeature	D014202
17042884	1947	1970	extrapyramidal syndrome	DiseaseOrPhenotypicFeature	D001480
17042884	1996	2006	quetiapine	ChemicalEntity	C069541
17042884	2057	2067	quetiapine	ChemicalEntity	C069541
17042884	2104	2119	Anticholinergic	ChemicalEntity	D018680
17042884	2149	2159	quetiapine	ChemicalEntity	C069541
17042884	2188	2201	bipolar mania	DiseaseOrPhenotypicFeature	D001714
17042884	2220	2223	EPS	DiseaseOrPhenotypicFeature	D001480
17042884	2235	2244	akathisia	DiseaseOrPhenotypicFeature	D017109
17042884	2251	2261	quetiapine	ChemicalEntity	C069541
17042884	Positive_Correlation	D014202	D008094	Novel
17042884	Positive_Correlation	D006220	D017109	Novel
17042884	Positive_Correlation	D006220	D014202	Novel
17042884	Positive_Correlation	D001480	D008094	Novel
17042884	Positive_Correlation	D001480	D006220	Novel